In this issue: Graphical abstract

ABSTRACT

Moritz M. Hollstein, Lennart Münsterkötter, Michael P. Schön, Armin Bergmann, Thea M. Husar, Anna Abratis, Abass Eidizadeh, Meike Schaffrinski, Karolin Zachmann, Anne Schmitz, Jason S. Holsapple, Hedwig Stanisz-Bogeski, Julie Schanz, Andreas Fischer, UWE GROß, Andreas Leha, Andreas E. Zautner, Moritz Schnelle, Luise Erpenbeck Booster with BNT162b2 elicits strong humoral and cellular immune responses independent of the prime vaccination, whereas ChAdOx1 nCoV-19 booster does not further enhance the cellular response. We demonstrate that the vaccine candidate (CuMV SB TT sb -RBD) is highly immunogenic in mice and is capable of inducing mucosal and systemic RBD as well as spike specific antibody responses. GRAPH Abbreviations CDX-0159, anti-KIT inhibitory monoclonal antibody;FcR, Fc receptor;KIT, KIT proto-oncogene, receptor tyrosine kinase;MRGPRX2, mas-related G protein-coupled receptor-X2;SCF, stem cell factor. [Extracted from the article] Copyright of Allergy is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)